These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2300679)

  • 1. Factors associated with increased noradrenaline levels in schizophrenic patients.
    Kemali D; Maj M; Galderisi S; Grazia Ariano M; Starace F
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):49-59. PubMed ID: 2300679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between CSF noradrenaline levels, C-EEG indicators of activation and psychosis ratings in drug-free schizophrenic patients.
    Kemali D; Maj M; Iorio G; Marciano F; Nolfe G; Galderisi S; Salvati A
    Acta Psychiatr Scand; 1985 Jan; 71(1):19-24. PubMed ID: 3969838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased noradrenaline levels in CSF and plasma of schizophrenic patients.
    Kemali D; Del Vecchio M; Maj M
    Biol Psychiatry; 1982 Jun; 17(6):711-7. PubMed ID: 7104421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF noradrenaline and schizophrenia.
    Kemali D; Maj M
    Am J Psychiatry; 1986 Jan; 143(1):126-7. PubMed ID: 3942277
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
    van Kammen DP; Peters J; van Kammen WB; Nugent A; Goetz KL; Yao J; Linnoila M
    Biol Psychiatry; 1989 Jun; 26(2):176-88. PubMed ID: 2472177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative EEG in never-treated schizophrenic patients.
    Omori M; Koshino Y; Murata T; Murata I; Nishio M; Sakamoto K; Horie T; Isaki K
    Biol Psychiatry; 1995 Sep; 38(5):305-9. PubMed ID: 7495924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM; Lindström LH
    Psychiatry Res; 1998 Nov; 81(2):101-10. PubMed ID: 9858027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
    Gattaz WF; Riederer P; Reynolds GP; Gattaz D; Beckmann H
    Psychiatry Res; 1983 Apr; 8(4):243-50. PubMed ID: 6576391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
    Lindström LH
    Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
    Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroencephalographic sleep in young, never-medicated schizophrenics. A comparison with delusional and nondelusional depressives and with healthy controls.
    Ganguli R; Reynolds CF; Kupfer DJ
    Arch Gen Psychiatry; 1987 Jan; 44(1):36-44. PubMed ID: 3800582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma norepinephrine in chronic schizophrenia.
    Breier A; Wolkowitz OM; Roy A; Potter WZ; Pickar D
    Am J Psychiatry; 1990 Nov; 147(11):1467-70. PubMed ID: 2221157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
    van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M
    Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic overactivity in chronic schizophrenia: evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations.
    Gomes UC; Shanley BC; Potgieter L; Roux JT
    Br J Psychiatry; 1980 Oct; 137():346-51. PubMed ID: 6160894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms of schizophrenia affect reference-independent measures of task-induced EEG alpha asymmetry.
    Merrin EL; Floyd TC
    Psychiatry Res; 1997 Mar; 74(1):47-62. PubMed ID: 10710162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG power variation in schizophrenic subgroups: effects of emotionally salient stimuli.
    Kessler C; Kling A
    Biol Psychiatry; 1991 Aug; 30(4):335-48. PubMed ID: 1912124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.